Apple’s Big Day, GlaxoSmithKline’s Generic Threat, and 3 More Hot Stocks

Apple (NASDAQ:AAPL): The tech world has its eyes transfixed on Apple on Tuesday, as the company is expected to release its new, high-end iPhone, which will speculatively incorporate a fingerprint scanner; also expected is a lower-end, cheaper alternative. Apple is anticipated to introduce a refreshed version of iOS 7 as well as iTunes Radio, but Bloomberg is reporting that a partnership with China Mobile (NYSE:CHL) won’t be forthcoming with Tuesday’s festivities.


GlaxoSmithKline (NYSE:GSK): The Food and Drug Administration has produced the requirements for the generic forms of Glaxo’s best-selling lung drug, Advair, which netted $8 billion in revenue last year. Bernstein analyst Tim Anderson describes the FDA’s terms as looking “fairly benign” for generic firms, while Citigroup contends that the expected fall in Advair sales could put a dent as large as 5 percent in Glaxo’s market cap.


Krispy Kreme Doughnuts (NYSE:KKD): Krispy Kreme will be opening its first location in Moscow this week, and the company plans to open 39 more stores in the region through its partnership with a local development firm. Russia marks the 22nd country for the doughnut maker.


Netflix (NASDAQ:NFLX): Users of Virgin Media’s (NASDAQ:VMED) set-top boxes will now have access to Netflix through their TV setup, making it the first time a major pay-TV operator embeds the beloved streaming service into its programming menu. It will soon be available to 1.7 million Virgin Media homes this year, beginning with a pilot launch to 40,000 homes this week, The Wall Street Journal reports.


Don’t Miss: Analyst: Apple’s Asia Deals May Add 35 Million iPhones.